About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Johnson & Johnson Inks $1 Billion Alzheimer's Pact With Elan

by VR Sreeraman on July 3, 2009 at 12:58 PM
Font : A-A+

Johnson & Johnson Inks $1 Billion Alzheimer's Pact With Elan

US health care giant Johnson & Johnson is to take up an 18.4 percent stake in Irish drugmaker Elan and acquire rights to Elan's Alzheimer's disease trial drugs, the companies said Thursday.

They anticipate concluding the transaction in the second half of 2009.

Advertisement

Johnson & Johnson will pay one billion dollars for the stake and assume Elan's activities with Wyeth under the Alzheimer's Immunotherapy Program (AIP).

It was also announced that the American firm would initially commit up to 500 million dollars to continue the development of a potential "first-in-class" treatment for slowing Alzheimer's disease, as well as other compounds.
Advertisement

The boards of directors of both Johnson & Johnson and Elan have each approved the transaction, which represents the culmination of an in-depth strategic review by Elan, a joint statement said.

"Johnson & Johnson's development capabilities, commercial experience and global reach will provide the foundation to accelerate the AIP Program development, and increase its potential availability for patients globally," said Sheri McCoy, Johnson & Johnson's global head for pharmaceuticals.

Elan will receive a 49.9 percent equity interest in a newly formed Johnson & Johnson company that will acquire the AIP Program and a similar share of the profits and certain royalty payments upon the commercialization of products under the collaboration with Wyeth, the statement said.

"This transaction will leverage Elan's unique scientific and clinical work and leadership in bringing treatments to market that potentially slow the progression of Alzheimer's disease," said Elan chief executive Kelly Martin.

Source: AFP
LIN
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Are Menopause Symptoms Troubling You?: Try these Options
Vaccination  And Counter  Measures Against  Monkeypox
Indian Railways Special Concession on Health Grounds
View all
Recommended Reading
News Archive
Date
Category
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Alzheimers Disease Creutzfeldt-Jakob Disease Diet and Alzheimer´s Disease Genetics of Alzheimer´s disease Mini-Mental Scale (Cognitive Function Test) 

Most Popular on Medindia

Selfie Addiction Calculator Post-Nasal Drip Indian Medical Journals The Essence of Yoga Iron Intake Calculator Drug Interaction Checker Hearing Loss Calculator Color Blindness Calculator Blood Donation - Recipients Drug - Food Interactions

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
CONSULT ONLINE WITH A DOCTOR